These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 35253252)

  • 41. Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics.
    Jun SH; Toosi H; Mold J; Engblom C; Chen X; O'Flanagan C; Hagemann-Jensen M; Sandberg R; Aparicio S; Hartman J; Roth A; Lagergren J
    Nat Commun; 2023 Feb; 14(1):982. PubMed ID: 36813776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Capturing Tumor Heterogeneity and Clonal Evolution by Circulating Tumor DNA Profiling.
    Scherer F
    Recent Results Cancer Res; 2020; 215():213-230. PubMed ID: 31605231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer is an adaptation that selects in animals against energy dissipation.
    Muller AWJ
    Med Hypotheses; 2017 Jul; 104():104-115. PubMed ID: 28673566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural and Chemotherapy-Induced Clonal Evolution of Tumors.
    Ibragimova MK; Tsyganov MM; Litviakov NV
    Biochemistry (Mosc); 2017 Apr; 82(4):413-425. PubMed ID: 28371598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The implications of clonal genome evolution for cancer medicine.
    Aparicio S; Caldas C
    N Engl J Med; 2013 Feb; 368(9):842-51. PubMed ID: 23445095
    [No Abstract]   [Full Text] [Related]  

  • 48. Clonal evolution of acute myeloid leukemia from diagnosis to relapse.
    Vosberg S; Greif PA
    Genes Chromosomes Cancer; 2019 Dec; 58(12):839-849. PubMed ID: 31478278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The next generation personalized models to screen hidden layers of breast cancer tumorigenicity.
    Afzali F; Akbari P; Naderi-Manesh H; Gardaneh M
    Breast Cancer Res Treat; 2019 Jun; 175(2):277-286. PubMed ID: 30810866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The evolutionary theory of cancer: challenges and potential solutions.
    Laplane L; Maley CC
    Nat Rev Cancer; 2024 Oct; 24(10):718-733. PubMed ID: 39256635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumour heterogeneity in the clinic.
    Bedard PL; Hansen AR; Ratain MJ; Siu LL
    Nature; 2013 Sep; 501(7467):355-64. PubMed ID: 24048068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clonal evolution models of tumor heterogeneity.
    Shlush LI; Hershkovitz D
    Am Soc Clin Oncol Educ Book; 2015; ():e662-5. PubMed ID: 25993239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Translating insights into tumor evolution to clinical practice: promises and challenges.
    Fittall MW; Van Loo P
    Genome Med; 2019 Mar; 11(1):20. PubMed ID: 30925887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers.
    Andersson N; Bakker B; Karlsson J; Valind A; Holmquist Mengelbier L; Spierings DCJ; Foijer F; Gisselsson D
    Cancer Res; 2020 Apr; 80(7):1512-1523. PubMed ID: 32041836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
    Gupta RG; Somer RA
    Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clonal evolution in cancer.
    Greaves M; Maley CC
    Nature; 2012 Jan; 481(7381):306-13. PubMed ID: 22258609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancers.
    Gopal P; Sarihan EI; Chie EK; Kuzmishin G; Doken S; Pennell NA; Raymond DP; Murthy SC; Ahmad U; Raja S; Almeida F; Sethi S; Gildea TR; Peacock CD; Adams DJ; Abazeed ME
    Nat Commun; 2019 Nov; 10(1):5143. PubMed ID: 31723142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer in light of experimental evolution.
    Sprouffske K; Merlo LM; Gerrish PJ; Maley CC; Sniegowski PD
    Curr Biol; 2012 Sep; 22(17):R762-71. PubMed ID: 22975007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases.
    Hu Z; Li Z; Ma Z; Curtis C
    Nat Genet; 2020 Jul; 52(7):701-708. PubMed ID: 32424352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal selection parallels between normal and cancer tissues.
    Salavaty A; Azadian E; Naik SH; Currie PD
    Trends Genet; 2023 May; 39(5):358-380. PubMed ID: 36842901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.